- Country: Russia
- Summary: No. Zz-56151-2021 Elisa Studies for the Presence of Antibodies and / or Antigen Antibodies to Hepatitis B Viruses, Hepatitis C, Syphilis Pathogen
- RUT Ref No: 61734517
- Deadline: 14 Jan 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 200000.00
- Notice Type: Tender
- Document Ref. No.: 0813500000121020222
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lot Name: - Study of blood serum on hepatitis in primary.
Research of blood serum to hepatitis to confirmation.
The test of blood serum on hepatitis with primary.
Research of blood serum on hepatitis with confirming.
Determination of antibodies to pale treponime. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNo. Zz-56151-2021 Elisa Studies for the Presence of Antibodies and / or Antigen Antibodies to Hepatitis B Viruses, Hepatitis C, Syphilis Pathogen - Russia Tender
The STATE STATE INSTITUTION OF THE UDMURT REPUBLIC "REGIONAL CENTER FOR PROCUREMENT OF THE UDMURT REPUBLIC", a Government sector organization in Russia, has announced a new tender for No. Zz-56151-2021 Elisa Studies for the Presence of Antibodies and / or Antigen Antibodies to Hepatitis B Viruses, Hepatitis C, Syphilis Pathogen. This tender is published on RussiaTenders under RUT Ref No: 61734517 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-01-14.
The estimated tender value is RUB 200000.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
